NCI Training Program in Translational Genomics and Precision Medicine Approaches in Cancer

About the Program

The T32 in Translational Genomics and Precision Medicine in Cancer (TGP) training program was developed in response to a new revolution of Big Data and the need for scientists to be trained in the discovery, integration and interpretation of translational genomics for precision medicine. The training plan allows qualified predoctoral or postdoctoral candidates to be educated and trained in-depth and breadth in state-of-the-art areas of translational genomics and precision medicine related to cancer.

The goal is to educate and train the next generation of scientists to understand broadly their role in driving precision medicine through discovery science and development of novel genomic analytical tools necessary to power this application in the clinical setting. In addition to a mentored research experience by one of our outstanding training faculty, both Ph.D. candidates and postdoctoral fellows are expected to gain interdisciplinary training in core competency areas critical to the future of translational genomic science.
 

Eligibility

Postdoctoral positions in the Translational Genomics and Precision Medicine in Cancer (TGP) Training Program at MD Anderson are available for U.S. citizens or permanent residents only. Predoctoral positions are also available, no U.S. citizenship required.

Candidates for positions on the T32 must be currently working with or propose to work with T32 faculty mentors and interested in training related to competency areas of the TGP program. We highly encourage selection of clinical co-mentors for T32 fellows accepted into the program to ensure a translational research experience.

Predoctoral fellows who have completed their first year of graduate training and have passed oral candidacy are preferred; however, the T32 Program will also consider strong applicants in their first year of graduate training, no U.S. citizenship required.